In Brief: Kensey Nash
This article was originally published in The Gray Sheet
Executive Summary
Kensey Nash: Relaunches 8F Angio-Seal in the European marketplace following a lapse of availability for several months "due to the interruption of production caused by damage from a roof collapse sustained at Kensey Nash's facility during a January snowstorm," the firm says. Angio-Seal, which is designed to seal arterial punctures following cardiac catheterization procedures, gained the CE Mark in September 1995. Kensey Nash received an FDA approvable letter for the device in July 1995...